ankylosing spondylitis |
309 |
anti-tumor necrosis factor-alpha treatment |
309 |
isokinetic test |
309 |
muscle performance |
309 |
cryptococcal meningitis |
361 |
giant cell vasculitis |
361 |
glucocorticoids |
361 |
confirmatory factor analysis |
315 |
depression |
315 |
disease activity |
315, 325 |
illness perceptions |
315 |
rheumatoid arthritis |
315, 325, 290 |
neuromyelitis optica spectrum disorder |
353 |
sjögren’s syndrome |
353, 284 |
tumefactive encephalitis |
353 |
cough |
303 |
leicester cough questionnaire |
303 |
primary sjögren’s syndrome |
303 |
xerotrachea |
303 |
anti-neutrophil cytoplasmic antibodies |
358 |
breast |
358 |
glomerulonephritis |
358 |
granulomatosis with polyangiitis |
358 |
knee |
339 |
magnetic resonance imaging |
339 |
osteoarthritis |
339, 325 |
roentgenogram |
339 |
complement 3 |
275 |
systemic lupus erythematosus |
275, 298 |
thrombocytopenia |
275 |
toll-like receptor 9 |
275 |
transforming growth factor-beta 1 |
275 |
pregnancy outcome |
298 |
pregnancy |
298 |
prognostic factors |
298 |
knee osteoarthritis |
333 |
neuropathic pain |
333 |
physical function |
333 |
risk factors |
333 |
fear-avoidance beliefs |
325 |
fibromyalgia |
325 |
allele groups |
290 |
human leukocyte antigen genotypes |
290 |
human leukocyte antigen system |
290 |
beta-2 microglobulin |
284 |
diagnosis |
284 |
saliva |
284 |
articular |
347 |
cartilage |
347 |
osteoarthritis of knee |
347 |
ultrasound imaging |
347 |
cavity |
365 |
18f-fluorodeoxyglucose |
365 |
immunoglobulin g4-related lung disease |
365 |
lung cancer |
365 |